Compounds > flubendazole
Page last updated: 2024-08-23

flubendazole and Breast Neoplasms

flubendazole has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fu, L; Li, Z; Liao, M; Mou, Y; Wu, L; Ye, J; Zhen, Y; Zhou, Y1
Cui, B; Hou, ZJ; Li, GH; Liu, Q; Long, ZJ; Luo, X; Peng, F; Wan, XY; Wang, XT; Wu, SJ; Xu, J; Xu, LZ; Yang, YL; Zhang, W; Zheng, FM1
Guo, M; Li, J; Liu, B; Xie, T; Zhang, L; Zhang, S; Zheng, Y1

Other Studies

3 other study(ies) available for flubendazole and Breast Neoplasms

ArticleYear
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer.
    International journal of molecular sciences, 2023, Oct-12, Volume: 24, Issue:20

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2023
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
    Oncotarget, 2015, Mar-20, Volume: 6, Issue:8

    Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Mebendazole; Mice; Mice, Nude; Neoplastic Stem Cells; Random Allocation; Xenograft Model Antitumor Assays

2015
Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.
    Molecular bioSystems, 2015, Volume: 11, Issue:11

    Topics: Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Line, Tumor; Cysteine Endopeptidases; Drug Discovery; Female; Humans; Mebendazole; Molecular Docking Simulation; Phylogeny; Protein Interaction Mapping; Reactive Oxygen Species; Small Molecule Libraries; Systems Biology

2015